1Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington. 2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
1Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Elizabeth J. Schafer, Surveillance ...
1Department of Physiology, College of Natural Science, Michigan State University, East Lansing, Michigan.
*Corresponding Author: Anne McTiernan, Public Health Sciences Division, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North, P.O. Box 19024, Seattle, WA 98109. E-mail: [email protected] ...
1Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
Suzhou Genhouse Pharmaceutical Co., Ltd., Suzhou, China.
Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...
University of Toledo College of Medicine and Life Sciences, Toledo, OH.
Search for other works by this author on: ...
Cancer Res (2025) 85 (8_Supplement_1): 6376.
Xavier University of Louisiana, New Orleans, LA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback